MEDP icon

Medpace

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 21.4%
Negative

Positive
Zacks Investment Research
17 hours ago
Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Positive
Zacks Investment Research
6 days ago
Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report?
Medpace (MEDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report?
Positive
Zacks Investment Research
6 days ago
Is Medpace (MEDP) Outperforming Other Medical Stocks This Year?
Here is how Medpace (MEDP) and Black Diamond (BDTX) have performed compared to their sector so far this year.
Is Medpace (MEDP) Outperforming Other Medical Stocks This Year?
Positive
Zacks Investment Research
12 days ago
SOLV vs. MEDP: Which Stock Is the Better Value Option?
Investors with an interest in Medical Services stocks have likely encountered both Solventum (SOLV) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
SOLV vs. MEDP: Which Stock Is the Better Value Option?
Neutral
Zacks Investment Research
13 days ago
Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors
Medpace (MEDP) closed at $536.17 in the latest trading session, marking a -1.42% move from the prior day.
Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors
Neutral
Business Wire
22 days ago
Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2025 financial results after the market close on Wednesday, October 22, 2025. The Company will host a conference call the following morning, Thursday, October 23, 2025, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended yo.
Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025
Positive
Seeking Alpha
28 days ago
Medpace: Profit Margin, Growth, And Repurchase Program Will Trump Legislative Headwinds (Rating Upgrade)
For this year, Medpace expects that its revenues will increase by 17.1%, which is an excellent growth rate. From 2019 to Q2 2025, Medpace's outstanding common shares declined by 22.16%, creating value for its investors. In the first half of 2025, the company had a capex-to-revenues ratio of 1.39%, which contributed to the company's high net profit margin.
Medpace: Profit Margin, Growth, And Repurchase Program Will Trump Legislative Headwinds (Rating Upgrade)
Neutral
Zacks Investment Research
29 days ago
SOLV or MEDP: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?
SOLV or MEDP: Which Is the Better Value Stock Right Now?
Positive
Zacks Investment Research
1 month ago
Why Medpace (MEDP) Outpaced the Stock Market Today
Medpace (MEDP) reached $496.41 at the closing of the latest trading day, reflecting a +1.18% change compared to its last close.
Why Medpace (MEDP) Outpaced the Stock Market Today
Positive
Zacks Investment Research
1 month ago
5 Non-Tech Nasdaq Stocks to Buy That Helped the Index Surge in 2025
Non-tech Nasdaq standouts like HAS, HOOD, IBKR, CELH and MEDP are fueling 2025's index surge.
5 Non-Tech Nasdaq Stocks to Buy That Helped the Index Surge in 2025